MedPath

Post-surgical analgesic efficacy of mgso4 versus lignocaine with acetaminophen in asthmatic patients

Not Applicable
Conditions
pain.
Pain, unspecified
Registration Number
IRCT20231124060161N2
Lead Sponsor
CMH Rawalpindi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

all ASA-I and II patients diagnosed with asthma by spirometry pre- and post-bronchodilator therapy with confirmation of reversibility presenting to the surgical department for elective laparoscopic cholecystectomy compliant and optimized on treatment.

Exclusion Criteria

major cardiac or respiratory disease
low ejection fraction
unoptimized for hypertension or diabetes
patients with cholecystitis, patients allergic to acetaminophen, MgSO4, lignocaine or nalbuphine
patient with a history of asthma exacerbation requiring admission in the last 8 weeks.
patients on oral or intravenous steroids for asthma
patients unwilling to be included in the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analgesia. Timepoint: 24hrs after first analgesics dose. Method of measurement: Visual Analogue Scale (VAS).
Secondary Outcome Measures
NameTimeMethod
Hypotension. Timepoint: 1,3,6 hours. Method of measurement: cardiac monitor, sphygmomanometer.;Respiratory depression. Timepoint: 1,3,6 hours. Method of measurement: pulse oximetry, cardiac monitor.;Nausea. Timepoint: 1,3,6 hours. Method of measurement: Visual assessment and patient complaints.;Vomiting. Timepoint: 1,3,6 hours. Method of measurement: Clinical assessment, patient complaints.
© Copyright 2025. All Rights Reserved by MedPath